Deals

BioCryst Fuels Reverse Merger with PIPE

By |

BioCryst Pharmaceuticals (BCRX) announced that it has raised $25 million in a Common Stock transaction. This transaction was completed without an agent, and the investors were Baker Brothers Advisors,

Bay City Capital, New Leaf Venture Partners, Panorama Capital, and Ventures West Capital. Issuer counsel was Wachtell, Lipton, Rosen & Katz, and investor counsel was Cooley. Concurrently with this Placement, the Company will complete a reverse merger with Presidio Pharmaceuticals. See the PlacementTracker Deal Summary.

Deals

Cempra Raises $25M in Common Stock PIPE

By |

Cempra (CEMP) announced that it has raised $25.1 million in a Common Stock transaction. The common stock was sold at $6.50 per share, an approximate

17% discount to the market price ($7.81) of CEMP at deal announcement. Jefferies & Company, Cowen and Company and Stifel Nicolaus Weisel acted as agents on the transaction. The Placement is subject to customary closing conditions and is expected to close by Oct. 24, 2012.

Deals

Cleveland BioLabs Raises $15M

By |

Cleveland BioLabs (CBLI) announced that it  raised $15 million in a CMPO/Overnight transaction. The common stock was sold at $2.00 per share, an approximate 19% discount to the market price ($2.48) of CBLI at deal announcement. A series of 3,750,000 Warrants with an exercise price of $3.00 per share (20.97% premium) was issued to the investors in this transaction. Oppenheimer & Co. acted as lead agent with Cantor Fitzgerald and Ladenburg Thalmann acting as co-agents. Burrill Merchant Advisors Group acted as financial advisor on the transaction.

Deals

Cowen Places Anacor Pharma CMPO

By |

 Anacor Pharmaceuticals (ANAC) announced that it has raised $24 million in a CMPO/Overnight transaction. The company is working on small-molecule therapeutics involving boron chemistry. The common stock was sold at $6.00 per share, an approximate 7% discount to the market price ($6.46) of ANAC at deal announcement. Cowen and Company, acted as the exclusive agent on the transaction. Placement Agent counsel was Goodwin Procter, and the issuer counsel was Cooley.